Icon (ICLR) Net Income towards Common Stockholders (2009 - 2026)
Icon (ICLR) posted quarterly Net Income towards Common Stockholders of $198.4 million for Q2 2026, down 29.22% year-over-year from $280.3 million in Q2 2025, and up 31.95% quarter-over-quarter from $150.4 million in Q1 2026.
Icon (ICLR) Net Income towards Common Stockholders (2009 - 2026) Analysis & Trends
Icon (ICLR) has reported Net Income towards Common Stockholders for 18 consecutive years, with $198.4 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Net Income towards Common Stockholders fell 29.22% year-over-year to $198.4 million; the TTM figure through Jun 2026 stood at $430.4 million (down 60.88% YoY), while the FY2025 annual figure was $229.3 million, down 80.28% from the prior year.
- Net Income towards Common Stockholders grew to $198.4 million in Q2 2026 per ICLR's latest filing, from $150.4 million in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $312.6 million in Q2 2024 and bottomed at -$177.1 million in Q4 2025.
- Historically, Net Income towards Common Stockholders has averaged $213.1 million across 5 years, with a median of $258.0 million in 2022.
- Annual changes were most pronounced in 2022 — Net Income towards Common Stockholders surged 237.04% — and 2025, when it sank 162.71%.
- Icon's Net Income towards Common Stockholders stood at $257.7 million in 2022, then climbed by 11.55% to $287.5 million in 2023, then slipped by 1.77% to $282.4 million in 2024, then tumbled by 162.71% to -$177.1 million in 2025, then soared by 212.02% to $198.4 million in 2026.
- Business Quant data shows ICLR's Net Income towards Common Stockholders at $198.4 million in Q2 2026, $150.4 million in Q1 2026, and -$177.1 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 1.76 Bn |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | 870.00 Mn |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | 338.41 Mn |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 339.00 Mn |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | 241.00 Mn |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | -85.11 Mn |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | 207.00 Mn |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | 232.90 Mn |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | 324.00 Mn |
| 10 | Icon | 12.55 Bn | 12.55 Bn | 479.29 Mn | 198.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 198.40 Mn |
| Mar 31, 2026 | 150.37 Mn |
| Dec 31, 2025 | -177.12 Mn |
| Sep 30, 2025 | 258.80 Mn |
| Jun 30, 2025 | 280.31 Mn |
| Mar 31, 2025 | 258.27 Mn |
| Dec 31, 2024 | 282.42 Mn |
| Sep 30, 2024 | 279.21 Mn |
| Jun 30, 2024 | 312.59 Mn |
| Mar 31, 2024 | 288.51 Mn |
| Dec 31, 2023 | 287.51 Mn |
| Sep 30, 2023 | 273.93 Mn |
| Jun 30, 2023 | 256.90 Mn |
| Mar 31, 2023 | 239.84 Mn |
| Dec 31, 2022 | 257.73 Mn |
| Sep 30, 2022 | 160.15 Mn |
| Jun 30, 2022 | 115.73 Mn |
| Mar 31, 2022 | 111.97 Mn |
| Dec 31, 2021 | 76.47 Mn |
| Sep 30, 2021 | 94.27 Mn |